Charles Lin

August 21, 2024

Dr. Lin is a board-certified ophthalmologist and fellowship-trained cornea specialist, focusing on the medical and surgical management of cornea conditions, as well as cataract surgery. He has launched cutting edge surgical procedures at Stanford including ultra-thin DSAEK, DMEK and DALK at Stanford. He conducts clinical trials on cornea transplantation and ocular inflammation and infections.

Dr. Lin received his AB in Environmental Science and Public Policy from Harvard University, graduating summa cum laude. He attended medical school at the University of California, San Francisco, where he received his M.D. with honors. Following an internship in Internal Medicine at Cedars-Sinai Hospital, he completed his ophthalmology residency at the University of California, San Francisco. Upon graduation, he was awarded the Heed Fellowship, a prestigious national award for ophthalmologists entering a career in academic medicine. He received subspecialty Cornea, External Disease, and Refractive Surgery training at the F.I. Proctor Foundation and University of California, San Francisco, one of the premier fellowships in the country.

Charles Lin

Recent Articles

CEO Update – June 2025

Bernie’s Quarterly Update – November 2024

Bernie’s Quarterly Update – July 2024

CorneaGen Launches CTAK, an Innovation for Improved Patient Outcomes